Analysis of clinical profile and prescription pattern of malaria in a tertiary care hospital in Karnataka, India


  • Raghu Murthy N. Department of Pharmacology Srinivas Institute of Medical Sciences and Research Centre, Surathkal, Mangalore, Karnataka, India
  • Seema Rai Department of Pharmacology Srinivas Institute of Medical Sciences and Research Centre, Surathkal, Mangalore, Karnataka, India



Artemisinin, cerebral malaria, Malaria, P. vivax


Background: Malaria is one of the leading causes of morbidity and mortality in developing countries like India. Plasmodium falciparum and Plasmodium vivax are the commonest species implicated for an increased incidence of malaria in India. The pattern of disease, signs, and symptoms vary from place to place, region to region due to demographic variations. The current study was undertaken to study the differences in the clinical profile of malaria, particularly signs and symptoms, complications and response to treatment in malaria.

Methods: A retrospective, single center, surveillance study was carried out at a tertiary health care center in Mangalore. All patients aged above 18 years diagnosed as malaria by peripheral smear method and rapid diagnostic tests were included in the study. The clinical features, complications, and response to treatment were noted.

Results: Fifty eight patients diagnosed as malaria were included in the study. Compared to other studies and nationwide incidences, here P. vivax emerged as the leading cause of malaria. All patients presented with fever varying from 3-20 days. About 30 patients complained of headache and 21 patients presented with malaise. In about 6 patient’s complications were seen. Majority of patients received artemisinin derivatives followed by chloroquine for treatment of malaria

Conclusions: Previous thinking that complications are only seen with P. falciparum has to be changed. Now many complications, mild as well as severe type are seen in P. vivax malaria. Drug resistance is another global problem which needs to be tackled wisely by systematic usage of antimalarials.


Santoshkumar RJ, Manjunath S, Sharanabasappa MA. Prescription pattern of antimalarial drugs in a tertiary care hospital. Asian Pac J Trop Dis. 2010;3(5):379-81.

World Health Organization. Fact sheet: malaria document center, 2015. Available at Accessed 18 January 2019.

National Health Portal, India. Fact sheet: National Vector Borne Disease Control Programme. Available at: Accessed 25 January 2019.

World Health Organization. Fact sheet: malaria document center, 2011. Available at Accessed 18 January 2019.

Olliaro P. Mortality Associated with Severe Plasmodium falciparum Malaria Increases with Age. Clin Infect Dis. 2008;47(2):158-60.

A study on drug prescribing pattern in Madurai city. Indian J Pharmacol. 2002;34:361-2.

Zurovac D, Rowe AK, Ochola SA, Noor AM, Midia B, English M, et al. Predictors of the quality of health worker treatment practices for uncomplicated malaria at government health facilities in Kenya. Int J Epidemiol. 2004;33:1080-91.

Ekanem OJ, Weisfied J, Amme LA, Nahlen BL, Ezedinachi EN, Walker O, et al. Sensitivity of Plasmodium Falciparum in Nigeria Children. Bull WHO. 1990;68:45-52.

Halchar S, Patil N, Hinchageri SS, Jivangi VM, Manjunath G, Geni A. Analysis of prescription pattern of antimalarials and its cost in malaria at a teaching hospital. Int J Pharmacol Therapeut. 2012;2(3):8-16.

Saravu K, Rishikesh K, Parikh CR. Risk factors and outcomes stratified by severity of acute kidney injury in malaria. PLoS One. 2014;9(3):e90419.

Antony J, Celine TM, Chacko M. Staging back of Malaria in Kerala, India: A Retrospective study. Int Res J Social Sci. 2013;2(12):42-6.

Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JS, Fosiko NG et al. Differentiating the pathologies of cerebral malaria by postmortem Parasite counts. Nat Med. 2004 Feb;10(2):143-5.

Mishra SK, Newton CR. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol. 2009;5(4):189-98.

Berendt AR, Tumer GD, Newbold CI. Cerebral malaria: the sequestration hypothesis. Parasitol Today. 1994;10(10):412-4.

van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006;22(11):503-8.

Moxon CA, Heyderman RS, Wassmer SC. Dysregulation of coagulation in cerebral malaria. Mol Biochem Parasitol. 2009;166(2):99-108.

Beare NA, Harding SP, Taylor TE, Lewallen S, Molyneux ME. Perfusion abnormalities in children with cerebral malaria and malarial retinopathy. J Infect Dis. 2009;199(2):263-71.

Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, Milner D, et al. The neuropathology of fatal cerebral malaria in malawian children. Am J Pathol. 2011;178(5):2146-58.

Clark IA, Rockett KA. The cytokine theory of human cerebral malaria. Parasitol Today. 1994;10(10):410-2.

Wassmer SC, Moxon CA, Taylor T, Grau GE, Molyneux ME, Craig AG. Vascular endothelial cells cultured from patients with cerebral or uncomplicated malaria exhibit differential reactivity to TNF. Cell Microbiol. 2011;13(2):198-209.

Kochar DK, Singh P, Agarwal P, Kochar SK, Pokharna R, Sareen PK. Malarial hepatitis. J Assoc Physicians India. 2003;51:1069-72.

Anand AC, Ranji C, Narula AS, Singh W. Histopathological changes of liver in malaria: a heterogenous syndrome? Natl Med J India. 1992;5:59-62.

Nautiyal A, Singh S, Parmeswaran G, DiSalle M. Hepatic dysfunction in a patient with Plasmodium vivax infection. Med Gen Med. 2005;7(1):8.

Prakash J, Singh AK, Kumar NS, Saxena RK. Acute renal failure in Plasmodium vivax malaria. J Assoc Physicians India. 2003;51:265-7.

Barsoum RS. Malarial acute renal failure. J Am Soc Nephrol. 2000;11(11):2147-54.

Pankaj P, Chandran K, Kumar S, Singh MK. Occurrence of thrombocytopenia in vivax malaria. J Evol Med Dental Sci. 2014;2(34):6458-65.

Saini T, Kumhar M, Barjartya HC. Plasmodium vivax malaria-is it really benign? J Indian Med Assoc. 2013;111(9):609-11.

Makkar RP, Mukhopadhyay S, Monga A, Monga A, Gupta AK. Plasmodium vivax malaria presenting with severe thrombocytopenia. Braz J Infect Dis. 2002;6(5):263-5.

Rodriguez-Morales AJ, Sanchez E, Varges M, Piccolo C, Colina R, Arria M, et al. Occurrence of Thrombocytopenia in Plasmodium vivax malaria. Clin Infect dis. 2005;4:130-1.

Harish R, Gupta S. Plasmodium vivax malaria presenting with severe thrombocytopenia, cerebral complications and hydrocephalus. Indian J Pediatr. 2009;76(5):551-2.

Erel O, Vural H, Aksoy N, Aslan G, Ulukanligil M. Oxidative stress of platelets and thrombocytopenia in patients with vivax malaria. Clin Biochem. 2001;34(4):341-4.

Karanikas G, Zedwitz-Liebenstein K, Eidherr H, Schuetz M, Sauerman R, Dudczak R, et al. Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patients. Thromb Haemost. 2004;91(3):553-7.

Scott CS, Van Zyl D, Ho E, Ruivo L, Mendelow B, Coetzer TL. Thrombocytopenia in patients with malaria, automated analysis of optical platelet count and platelet clumps with Cell Dyn CD4000 analyser. Clin Lab Haematol. 2002;24(5):295-302.

Untaroiu AM, Carey MA, Guler JL, Papin JA. Leveraging the effects of chloroquine on resistant malaria parasites for combination therapies. BMC Bioinformatics. 2019;20(1):186.

Kochar DK, Das A, Kochar A, Middha S, Acharya J, Tanwar GS, et al. A prospective study on adult patients of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed infection from Bikaner, northwest India. J Vector Borne Dis. 2014;51(3):200-10.




How to Cite

N., R. M., & Rai, S. (2019). Analysis of clinical profile and prescription pattern of malaria in a tertiary care hospital in Karnataka, India. International Journal of Basic & Clinical Pharmacology, 8(8), 1744–1748.



Original Research Articles